Hagerman, Allison

Track

Insider profile

Performance

Overall performance
Performance over holding periods
30 days 90 days 120 days
Average return 988% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Hagerman, Allison's trades of Oncolytics Biotech Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
71.08
Quantity 86,883 +11.1%
Value US$2,548,907
Transaction date
Purchase
Price
216.97
Quantity 65,399 -10.2%
Value CA$4,592,638
Transaction date
Purchase
Price
405.38
Quantity 63,875
Value CA$448,544
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-13 2026-02-12
B Purchase
86,883 +11.1%
71.08
US$2,548,907 		86,883 +11.1% 71.08 US$2,548,907
2025-07-18 2025-07-17
B Purchase
65,399 -10.2%
216.97
CA$4,592,638 		65,399 -10.2% 216.97 CA$4,592,638
2022-06-17 2022-06-16
B Purchase
63,875
405.38
CA$448,544 		63,875 405.38 CA$448,544